middle.news
How Acrux Plans to Capture Saudi Arabia’s Acne Treatment Market with Dapsone Gel
9:19am on Thursday 31st of July, 2025 AEST
•
Pharmaceuticals
Read Story
How Acrux Plans to Capture Saudi Arabia’s Acne Treatment Market with Dapsone Gel
9:19am on Thursday 31st of July, 2025 AEST
Key Points
10-year licensing, sales, marketing, and distribution agreement with Servacure
Dapsone 5% Gel FDA-approved for acne treatment in the US
Servacure responsible for regulatory approval and manufacturing coordination in Saudi Arabia
Fixed fee per unit payment structure to Acrux
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Acrux (ASX:ACR)
OPEN ARTICLE